US Patent Issued to Ablynx on Nov. 25 for "Method of screening for anti-drug antibodies against immunoglobulin single variable domain-based drugs" (Belgian Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,957, issued on Nov. 25, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium).

"Method of screening for anti-drug antibodies against immunoglobulin single variable domain-based drugs" was invented by Annelies Coddens (Oudenaarde, Belgium), Veerle Snoeck (Zingem, Belgium), Marie-Ange Buyse (Merelbeke, Belgium) and Carlo Boutton (Wielsbeke, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to improved immunogenicity assays and methods for performing the same. In particular, the present invention relates to improved immunogenicity assays that are capable of distinguishing neutralizing anti-drug antibodies from non-n...